![Susan Abushakra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Abushakra
Directeur Technique/Scientifique/R&D chez
ALZHEON, INC.
Profil
Susan Abushakra is the founder of Bonti, Inc. founded in 2015, where she holds the title of Chief Medical Officer.
She is currently the Chief Medical Officer at Alzheon, Inc. since 2015 and a Member of the Alzheimer's Association.
Dr. Abushakra's former positions include Chief Medical Officer at Transition Therapeutics, Inc., Vice President-Clinical Development at Elan Corp., and Chief Medical Officer at Perrigo Co. Plc in 2014.
Dr. Abushakra received a doctorate degree from the American University of Beirut.
Postes actifs de Susan Abushakra
| Sociétés | Poste | Début |
|---|---|---|
| ALZHEON, INC. | Directeur Technique/Scientifique/R&D | 01/07/2015 |
Bonti, Inc.
 Bonti, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments | Fondateur | 01/01/2015 |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Corporate Officer/Principal | - |
Anciens postes connus de Susan Abushakra
| Sociétés | Poste | Fin |
|---|---|---|
| PERRIGO COMPANY PLC | Directeur Technique/Scientifique/R&D | 01/06/2014 |
| ELAN CORPORATION | Corporate Officer/Principal | - |
| TRANSITION THERAPEUTICS INC | Directeur Technique/Scientifique/R&D | - |
Formation de Susan Abushakra
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
American University of Beirut
 American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Commercial Services |
Elan Corp.
 Elan Corp. Pharmaceuticals: MajorHealth Technology Engages in the nursing care business | Health Technology |
Perrigo Co. Plc
 Perrigo Co. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatments | Health Technology |
Choisissez Zonebourse 
